194 related articles for article (PubMed ID: 31439463)
41. Management of cystic fibrosis related diabetes: a survey of UK cystic fibrosis centers.
Mohan K; Miller H; Burhan H; Ledson MJ; Walshaw MJ
Pediatr Pulmonol; 2008 Jul; 43(7):642-7. PubMed ID: 18500737
[TBL] [Abstract][Full Text] [Related]
42. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
43. Improved outcomes in cystic fibrosis using modified
Reamer C; O'Malley C; Nufer J; Savant A
BMJ Open Qual; 2020 Jul; 9(3):. PubMed ID: 32675178
[TBL] [Abstract][Full Text] [Related]
44. Diabetes-related mortality in adults with cystic fibrosis. Role of genotype and sex.
Lewis C; Blackman SM; Nelson A; Oberdorfer E; Wells D; Dunitz J; Thomas W; Moran A
Am J Respir Crit Care Med; 2015 Jan; 191(2):194-200. PubMed ID: 25479583
[TBL] [Abstract][Full Text] [Related]
45. Cystic fibrosis-related diabetes mellitus: etiology, evaluation, and management.
Fischman D; Nookala VK
Endocr Pract; 2008 Dec; 14(9):1169-79. PubMed ID: 19158056
[TBL] [Abstract][Full Text] [Related]
46. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
47. Long-term benefits in lung function and nutritional status of strict metabolic control of cystic fibrosis-related diabetes.
Martín-Frías M; Máiz L; Carcavilla A; Barrio R
Arch Bronconeumol; 2011 Oct; 47(10):531-4. PubMed ID: 21798655
[TBL] [Abstract][Full Text] [Related]
48. Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium.
Liou TG; Jensen JL; Allen SE; Brayshaw SJ; Brown MA; Chatfield B; Koenig J; McDonald C; Packer KA; Peet K; Radford P; Reineke LM; Otsuka K; Wagener JS; Young D; Marshall BC
BMJ Open Diabetes Res Care; 2016; 4(1):e000183. PubMed ID: 27158517
[TBL] [Abstract][Full Text] [Related]
49. Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries.
Volkova N; Moy K; Evans J; Campbell D; Tian S; Simard C; Higgins M; Konstan MW; Sawicki GS; Elbert A; Charman SC; Marshall BC; Bilton D
J Cyst Fibros; 2020 Jan; 19(1):68-79. PubMed ID: 31196670
[TBL] [Abstract][Full Text] [Related]
50. Characteristics of cystic fibrosis-related diabetes: Data from two different sources the European cystic fibrosis society patient registry and German/Austrian diabetes prospective follow-up registry.
Prinz N; Zolin A; Konrad K; Nährlich L; Laubner K; Olesen HV; Bauer M; Jung A; Frischer T; Holl RW;
Pediatr Diabetes; 2019 May; 20(3):255-262. PubMed ID: 30761696
[TBL] [Abstract][Full Text] [Related]
51. Microalbuminuria as a screening tool in cystic fibrosis-related diabetes.
Dobson L; Stride A; Bingham C; Elworthy S; Sheldon CD; Hattersley AT
Pediatr Pulmonol; 2005 Feb; 39(2):103-7. PubMed ID: 15573388
[TBL] [Abstract][Full Text] [Related]
52. Overweight and obesity in patients with cystic fibrosis: a center-based analysis.
Hanna RM; Weiner DJ
Pediatr Pulmonol; 2015 Jan; 50(1):35-41. PubMed ID: 24757043
[TBL] [Abstract][Full Text] [Related]
53. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
54. Continuous glucose monitoring in a cystic fibrosis patient to predict pulmonary exacerbation?
Inman TB; Proudfoot JA; Lim M; Demeterco-Berggren C
J Cyst Fibros; 2017 Sep; 16(5):628-630. PubMed ID: 28625799
[TBL] [Abstract][Full Text] [Related]
55. Recent trends in cystic fibrosis-related diabetes.
Nathan BM; Laguna T; Moran A
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):335-41. PubMed ID: 20489612
[TBL] [Abstract][Full Text] [Related]
56. Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.
Khare S; Desimone M; Kasim N; Chan CL
J Clin Transl Endocrinol; 2022 Mar; 27():100290. PubMed ID: 34917485
[TBL] [Abstract][Full Text] [Related]
57. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
Moheet A; Moran A
Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
[TBL] [Abstract][Full Text] [Related]
58. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
Lek N; Acerini CL
Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
[TBL] [Abstract][Full Text] [Related]
59. Cystic fibrosis related diabetes: Medical management.
Ode KL; Chan CL; Granados A; Moheet A; Moran A; Brennan AL
J Cyst Fibros; 2019 Oct; 18 Suppl 2():S10-S18. PubMed ID: 31679720
[TBL] [Abstract][Full Text] [Related]
60. Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges.
Boudreau V; Reynaud Q; Dubois CL; Coriati A; Desjardins K; Durieu I; Rabasa-Lhoret R
Can J Diabetes; 2016 Oct; 40(5):466-470. PubMed ID: 27737759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
